Friday, October 25, 2013

FDA Approves Bastyr Turkey Tail Mushroom Clinical Trial for Cancer Patients

The research teams at Bastyr University are studying the efficacy of medicinal mushrooms and cancer.  Recently, the FDA has approved a plan to begin clinical trials in 2013 for prostate cancer and the use of medicinal mushrooms.  See more information on this very exciting research @ Bastyr University

Torkelson et al (2012) published research in a phase 1 clinical trial of Trametes versicolor, also known as Turkey Tail, in women with Breast Cancer. The findings of the study suggest that  Tramets versicolor may improve the immune status in immunocompromised breast cancer patients following chemotherapy and radiation.  See the entire article @ Phase 1 Clinical Trial of Trametes versicolor in women with Breast Cancer